FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1852-1857 June 30, 1994 Number 26 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The results of trials of the primary prevention of coronary heart disease have suggested that treating hypertension with high doses of thiazide diuretic drugs might increase the risk of sudden death from cardiac causes. In contrast, treatment with low doses of thiazide reduces the risk of coronary heart disease.

Methods To examine the association between thiazide treatment for hypertension and the occurrence of primary cardiac arrest, we conducted a population-based case-control study among enrollees of a health maintenance organization. The case patients were 114 persons with hypertension who had a primary cardiac arrest from 1977 through 1990. The control patients were a stratified random sample of 535 persons with hypertension. The patients' treatment was assessed with the use of a computerized pharmacy data base. Records of their ambulatory care were reviewed to determine other clinical characteristics.

Results The risk of primary cardiac arrest among patients receiving combined thiazide and potassium-sparing diuretic therapy was lower than that among patients treated with a thiazide without potassium-sparing therapy (odds ratio, 0.3; 95 percent confidence interval, 0.1 to 0.7). As compared with low-dose thiazide therapy (25 mg daily), moderate-dose therapy (50 mg daily) was associated with a moderate increase in risk (odds ratio, 1.7; 95 percent confidence interval, 0.7 to 4.5), and high-dose therapy (100 mg daily) was associated with a larger increase in risk (odds ratio, 3.6; 95 percent confidence interval, 1.2 to 10.8) (P value for trend, 0.02). The addition of a potassium-sparing drug to low-dose thiazide therapy was associated with a reduced risk of cardiac arrest (odds ratio, 0.4; 95 percent confidence interval, 0.1 to 1.5).

Conclusions Both the dose of thiazide drugs and the addition of potassium-sparing drugs influence the risk of primary cardiac arrest. These results may explain the differences in the effect of antihypertensive therapy on mortality from coronary heart disease in previous clinical trials.

Source Information

From the Cardiovascular Health Research Unit, the Departments of Medicine (D.S.S., B.M.P., T.D.K., K.G.W., L.C., M.K.C.), Epidemiology (D.S.S., B.M.P., T.D.K.), Biostatistics (T.E.R., X.L.), and Health Services (B.M.P., T.D.K., E.H.W.), University of Washington, Seattle; the Epicore Centre, Division of Cardiology, University of Alberta, Edmonton, Alta., Canada (P.M.R.); and the Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle (E.H.W.). Presented in part at the 33rd annual scientific meeting of the Council on Epidemiology and Prevention of the American Heart Association, Sante Fe, N.M., March 18, 1993.

Address reprint requests to Dr. Siscovick at the Cardiovascular Health Research Unit, Metropolitan Park 2 Bldg., Suite 1360, 1730 Minor Ave., Seattle, WA 98101.

Full Text of this Article

Related Letters:

Diuretic Therapy and the Risk of Cardiac Arrest
Moser M., Gifford R., Siscovick D. S., Koepsell T. D., Raghunathan T.E.
Extract | Full Text  
N Engl J Med 1994; 331:1235-1236, Nov 3, 1994. Correspondence

This article has been cited by other articles:

• Kaplan, N. M. (2009). The Choice of Thiazide Diuretics: Why Chlorthalidone May Replace Hydrochlorothiazide. Hypertension 54: 951-953 [Full Text]  
• Ellison, D. H., Loffing, J. (2009). Thiazide Effects and Adverse Effects: Insights From Molecular Genetics. Hypertension 54: 196-202 [Full Text]  
• Law, M R, Morris, J K, Wald, N J (2009). Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338: b1665-b1665 [Abstract] [Full Text]  
• Messerli, F. H., Bangalore, S. (2009). Antihypertensive Efficacy of Aliskiren: Is Hydrochlorothiazide an Appropriate Benchmark?. Circulation 119: 371-373 [Full Text]  
• Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., Stein, C. M. (2009). Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death. NEJM 360: 225-235 [Abstract] [Full Text]  
• Bleyer, A. J. (2009). CLUES AT THE SCENE OF THE CRIME: SUDDEN DEATH IN DIALYSIS PATIENTS. pdi 29: 23-25 [Full Text]  
• Carter, B. L., Einhorn, P. T., Brands, M., He, J., Cutler, J. A., Whelton, P. K., Bakris, G. L., Brancati, F. L., Cushman, W. C., Oparil, S., Wright, J. T. Jr (2008). Thiazide-Induced Dysglycemia: Call for Research From a Working Group From the National Heart, Lung, and Blood Institute. Hypertension 52: 30-36 [Full Text]  
• Ahmed, A., Zannad, F., Love, T. E., Tallaj, J., Gheorghiade, M., Ekundayo, O. J., Pitt, B. (2007). A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28: 1334-1343 [Abstract] [Full Text]  
• Maeder, M., Rickli, H., Sticherling, C., Widmer, R., Ammann, P. (2007). Hypokalaemia and sudden cardiac death--lessons from implantable cardioverter defibrillators. Emerg. Med. J. 24: 206-208 [Abstract] [Full Text]  
• Schiffrin, E. L. (2006). Effects of Aldosterone on the Vasculature. Hypertension 47: 312-318 [Full Text]  
• Ma, J., Albornoz, F., Yu, C., Byrne, D. W., Vaughan, D. E., Brown, N. J. (2005). Differing Effects of Mineralocorticoid Receptor-Dependent and -Independent Potassium-Sparing Diuretics on Fibrinolytic Balance. Hypertension 46: 313-320 [Abstract] [Full Text]  
• Morganti, A. (2005). Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No. J. Am. Soc. Nephrol. 16: S70-S73 [Abstract] [Full Text]  
• Mancia, G., Grassi, G. (2005). Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?. J. Am. Soc. Nephrol. 16: S74-S77 [Abstract] [Full Text]  
• Psaty, B. M., Lumley, T., Furberg, C. D. (2004). Chlorthalidone vs Other Low-Dose Diuretics--Reply. JAMA 292: 1817-1817 [Full Text]  
• Ray, W. A., Murray, K. T., Meredith, S., Narasimhulu, S. S., Hall, K., Stein, C. M. (2004). Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes. NEJM 351: 1089-1096 [Abstract] [Full Text]  
• Shah, S U, Anjum, S, Littler, W A (2004). Use of diuretics in cardiovascular diseases: (1) heart failure. Postgrad. Med. J. 80: 201-205 [Abstract] [Full Text]  
• Macdonald, J. E., Struthers, A. D. (2004). What is the optimal serum potassium level in cardiovascular patients?. J Am Coll Cardiol 43: 155-161 [Abstract] [Full Text]  
• Miltiadous, G., Mikhailidis, D. P., Elisaf, M. (2003). Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs. J CARDIOVASC PHARMACOL THER 8: 267-276 [Abstract]  
• Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L. Jr, Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T. Jr, Roccella, E. J., the National High Blood Pressure Education Program, (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252 [Abstract] [Full Text]  
• Gheorghiade, M., Niazi, I., Ouyang, J., Czerwiec, F., Kambayashi, J.-i., Zampino, M., Orlandi, C. (2003). Vasopressin V2-Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure: Results From a Double-Blind, Randomized Trial. Circulation 107: 2690-2696 [Abstract] [Full Text]  
• Yu, T., Weil, M. H., Tang, W., Sun, S., Klouche, K., Povoas, H., Bisera, J. (2002). Adverse Outcomes of Interrupted Precordial Compression During Automated Defibrillation. Circulation 106: 368-372 [Abstract] [Full Text]  
• de Lorgeril, M., Salen, P., Defaye, P., Mabo, P., Paillard, F. (2002). Dietary prevention of sudden cardiac death. Eur Heart J 23: 277-285 [Full Text]  
• Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., Murray, K. T. (2001). Antipsychotics and the Risk of Sudden Cardiac Death. Arch Gen Psychiatry 58: 1161-1167 [Abstract] [Full Text]  
• Frohlich, E. D. (2001). Local Hemodynamic Changes in Hypertension: Insights for Therapeutic Preservation of Target Organs. Hypertension 38: 1388-1394 [Abstract] [Full Text]  
• Wyse, D. G., Friedman, P. L., Brodsky, M. A., Beckman, K. J., Carlson, M. D., Curtis, A. B., Hallstrom, A. P., Raitt, M. H., Wilkoff, B. L., Greene, H. L., for the AVID Investigators, (2001). Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol 38: 1718-1724 [Abstract] [Full Text]  
• Knight, E. L., Avorn, J. (2001). Quality Indicators for Appropriate Medication Use in Vulnerable Elders. ANN INTERN MED 135: 703-710 [Full Text]  
• Mazeika, P (2001). Aborted sudden cardiac death: a clinical perspective. Postgrad. Med. J. 77: 363-370 [Abstract] [Full Text]  
• Brown, M.J., Palmer, C.R., Castaigne, A., de Leeuw, P.W., Mancia, G., Rosenthal, T., Ruilope, L.M. (2001). Principal results from the international nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT). Eur Heart J Suppl 3: B20-B26 [Abstract]  
• Albert, C. M, Ruskin, J. N (2001). Risk stratifiers for sudden cardiac death (SCD) in the community: primary prevention of SCD. Cardiovasc Res 50: 186-196 [Full Text]  
• Sotoodehnia, N., Zivin, A., Bardy, G. H, Siscovick, D. S (2001). Reducing mortality from sudden cardiac death in the community: lessons from epidemiology and clinical applications research. Cardiovasc Res 50: 197-209 [Abstract] [Full Text]  
• Laragh, J. H., Sealey, J. E. (2001). K+ Depletion and the Progression of Hypertensive Disease or Heart Failure : The Pathogenic Role of Diuretic-Induced Aldosterone Secretion. Hypertension 37: 806-810 [Full Text]  
• Whitsel, E.A., Raghunathan, T.E., Pearce, R.M., Lin, D., Rautaharju, P.M., Lemaitre, R., Siscovick, D.S. (2001). RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease. Eur Heart J 22: 165-173 [Abstract]  
• Franse, L. V., Pahor, M., Di Bari, M., Somes, G. W., Cushman, W. C., Applegate, W. B. (2000). Hypokalemia Associated With Diuretic Use and Cardiovascular Events in the Systolic Hypertension in the Elderly Program. Hypertension 35: 1025-1030 [Abstract] [Full Text]  
• Frohlich, E. D. (1999). The necessity for recognition and treatment of patients with "mild" hypertension. J Am Coll Cardiol 34: 1369-1377 [Abstract] [Full Text]  
• Frohlich, E. D. (1999). Risk Mechanisms in Hypertensive Heart Disease. Hypertension 34: 782-789 [Abstract] [Full Text]  
• Cooper, H. A., Dries, D. L., Davis, C. E., Shen, Y. L., Domanski, M. J. (1999). Diuretics and Risk of Arrhythmic Death in Patients With Left Ventricular Dysfunction. Circulation 100: 1311-1315 [Abstract] [Full Text]  
• Temple, R. (1999). Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?. JAMA 282: 790-795 [Full Text]  
• Wahr, J. A., Parks, R., Boisvert, D., Comunale, M., Fabian, J., Ramsay, J., Mangano, D. T., for the Multicenter Study of Perioperative Ischemi, (1999). Preoperative Serum Potassium Levels and Perioperative Outcomes in Cardiac Surgery Patients. JAMA 281: 2203-2210 [Abstract] [Full Text]  
• Domanski, M. J., Exner, D. V., Borkowf, C. B., Geller, N. L., Rosenberg, Y., Pfeffer, M. A. (1999). Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 33: 598-604 [Abstract] [Full Text]  
• Pahor, M., Shorr, R. I., Somes, G. W., Cushman, W. C., Ferrucci, L., Bailey, J. E., Elam, J. T., Applegate, W. B. (1998). Diuretic-Based Treatment and Cardiovascular Events in Patients With Mild Renal Dysfunction Enrolled in the Systolic Hypertension in the Elderly Program. Arch Intern Med 158: 1340-1345 [Abstract] [Full Text]  
• Moser, M. (1998). Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension?. JAMA 279: 1813-1816 [Abstract] [Full Text]  
• Savage, P. J., Pressel, S. L., Curb, J. D., Schron, E. B., Applegate, W. B., Black, H. R., Cohen, J., Davis, B. R., Frost, P., Smith, W., Gonzalez, N., Guthrie, G. P., Oberman, A., Rutan, G., Probstfield, J. L., Stamler, J., for the SHEP Cooperative Research Group, (1998). Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension: The Systolic Hypertension in the Elderly Program. Arch Intern Med 158: 741-751 [Abstract] [Full Text]  
• Walma, E., van Dooren, C., Prins, A., van der Does, E., Hoes, A. (1997). Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial. BMJ 315: 464-468 [Abstract] [Full Text]  
• Gottdiener, J. S., Reda, D. J., Massie, B. M., Materson, B. J., Williams, D. W., Anderson, R. J. (1997). Effect of Single-Drug Therapy on Reduction of Left Ventricular Mass in Mild to Moderate Hypertension: Comparison of Six Antihypertensive Agents. Circulation 95: 2007-2014 [Abstract] [Full Text]  
• Psaty, B. M., Smith, N. L., Siscovick, D. S., Koepsell, T. D., Weiss, N. S., Heckbert, S. R., Lemaitre, R. N., Wagner, E. H., Furberg, C. D. (1997). Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis. JAMA 277: 739-745 [Abstract]  
• Siscovick, D. S., Raghunathan, T.E., Rautaharju, P., Psaty, B. M., Cobb, L. A., Wagner, E. H. (1996). Clinically Silent Electrocardiographic Abnormalities and Risk of Primary Cardiac Arrest Among Hypertensive Patients. Circulation 94: 1329-1333 [Abstract] [Full Text]  
• Frohlich, E. D., Zanchetti, A. (1996). Antihypertensive Therapy: Safety and Efficacy of Drugs and Publications. Hypertension 27: 317-318 [Full Text]  
• Glynn, R. J., Brock, D. B., Harris, T., Havlik, R. J., Chrischilles, E. A., Ostfeld, A. M., Taylor, J. O., Hennekens, C. H. (1995). Use of Antihypertensive Drugs and Trends in Blood Pressure in the Elderly. Arch Intern Med 155: 1855-1860 [Abstract]  
• Psaty, B. M., Heckbert, S. R., Koepsell, T. D., Siscovick, D. S., Raghunathan, T. E., Weiss, N. S., Rosendaal, F. R., Lemaitre, R. N., Smith, N. L., Wahl, P. W., Wagner, E. H., Furberg, C. D. (1995). The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies. JAMA 274: 620-625 [Abstract]  
• Psaty, B. M., Koepsell, T. D., Yanez, N. D., Smith, N. L., Manolio, T. A., Heckbert, S. R., Borhani, N. O., Gardin, J. M., Gottdiener, J. S., Rutan, G. H., Siscovick, D. S., Furberg, C. D. (1995). Temporal Patterns of Antihypertensive Medication Use Among Older Adults, 1989 Through 1992: An Effect of the Major Clinical Trials on Clinical Practice?. JAMA 273: 1436-1438 [Abstract]  
• Singer, D. R. J., Markandu, N. D., Cappuccio, F. P., Miller, M. A., Sagnella, G. A., MacGregor, G. A. (1995). Reduction of Salt Intake During Converting Enzyme Inhibitor Treatment Compared With Addition of a Thiazide. Hypertension 25: 1042-1044 [Abstract] [Full Text]  
• Cook, N. R., Cohen, J., Hebert, P. R., Taylor, J. O., Hennekens, C. H. (1995). Implications of Small Reductions in Diastolic Blood Pressure for Primary Prevention. Arch Intern Med 155: 701-709 [Abstract]  
• Moser, M., Gifford, R., Siscovick, D. S., Koepsell, T. D., Raghunathan, T.E. (1994). Diuretic Therapy and the Risk of Cardiac Arrest. NEJM 331: 1235-1236 [Full Text]  
• (1994). THIAZIDE DIURETICS AND PRIMARY CARDIAC ARREST. JWatch General 1994: 3-3 [Full Text]  
• Bigger, J. T. (1994). Diuretic Therapy, Hypertension, and Cardiac Arrest. NEJM 330: 1899-1900 [Full Text]